Peter Langmann

721 citations
37 papers · 571 · h-index 15

Impact in

  • Virology top 5%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 13
    • Antifungal resistance and susceptibility 2
    • Pneumocystis jirovecii pneumonia detection and treatment 9
    • Liver Disease Diagnosis and Treatment 2

Peter Langmann

36 papers receiving 546 citations

Peers

Peter Langmann
Comparison fields: 5 of 62
  • Virology 146
  • Infectious Diseases 302
  • Emergency Medicine 72
  • Hepatology 41
  • Epidemiology 120
Replace Michael Zilly with:
Michael Zilly Germany
J Biollaz Switzerland
Laurene H. Wang United States
Neil Buss Switzerland
Rosa María López Spain
E.C.M. van Gorp Netherlands
J.L. Pellegrin France
Kristel M. L. Crommentuyn Netherlands
Hamid Hasson Italy
Aurélie Barrail‐Tran France
Peter Langmann relative to Michael Zilly Germany Michael Zilly's profile →
Citations per field
00.5×
Michael Zilly · 1×
Citations per year

Countries citing papers authored by Peter Langmann

Since Specialization
Citations

This map shows the geographic impact of Peter Langmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langmann more than expected).

Fields of papers citing papers by Peter Langmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Langmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langmann. The network helps show where Peter Langmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Langmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Langmann Line = papers co-authored together Peter Langmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200457
2
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment.
200355
3 200138
4 199936
5 201036
6 200936
7
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients.
200233
8 200525
9 199822
10 199621
11 200221
12 200419
13
Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir.
200019
14
Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.
200217
15 200516
16
Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis.
200013
17 200212
18 200312
19
Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
200311
20 199610

About Peter Langmann

Peter Langmann is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Pediatrics, Perinatology and Child Health, having authored 37 papers that have together received 571 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), HIV Research and Treatment (9 papers), Hepatitis C virus research (8 papers), Pharmacological Effects and Toxicity Studies (4 papers), Antifungal resistance and susceptibility (2 papers), Metabolism and Genetic Disorders (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Virology (146 citations), Infectious Diseases (302 citations), Emergency Medicine (72 citations), Hepatology (41 citations) and Epidemiology (120 citations). Peter Langmann has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Hartwig Klinker, Michael Zilly, Benedikt Weißbrich, Ralf Winzer, Erik A. Richter, Steffen Desch, Ernst Richter, Franz Tollmann, Jörg Schubert and Werner Heinz. Their work appears in journals such as Infection, Journal of Chromatography B, Antimicrobial Agents and Chemotherapy, Medical Mycology and Annals of Clinical Microbiology and Antimicrobials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact